Tissue targeted antigenic activation of the immune response to treat cancers

• 收藏
• 分享

专利权人:

QU Biologics Inc

发明人:

Gunn Harold David

申请号：

NZ71588207

公开号：

NZ715882A

申请日:

2007.10.25

申请国别(地区):

NZ

年份:

2017

代理人:

摘要：

Disclosed is the use of a an effective amount of an antigenic composition comprising attenuated cells of one or more microbial pathogen, wherein the microbial pathogen is selected from the group consisting of Klebsiella pneumoniae, Streptococcus pneumoniae, Moraxella catarrhalis, Mycoplasma pneumoniae, Haemophilus influenza, influenza virus, adenovirus, respiratory syncytial virus, and parainfluenza virus, in the manufacture of a medicament for the treatment of cancer situated in a lung tissue in a human patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/